JID VisualDx Quiz
JID VisualDx Quiz: December 2014 Arsalan Shabbir1 and Robert S. Kirsner1 Journal of Investigative Dermatology (2014) 134, e23. doi:10.1038/jid.2014.435
JID and Logical Images, Inc., have cooperated to offer the JID VisualDx Quiz, incorporating diagnostic images from VisualDx’s vast database. Questions relate to the image as well as to selected articles in JID, which are listed after the questions. Answers will be posted as supplementary material. We hope you enjoy this challenge.
Image appears with permission from VisualDx. © Logical Images, Inc.
QUESTIONS 1. What is your diagnosis? a. Bullous pemphigoid. b. Epidermolysis bullosa acquista. c. Bullous drug reaction. d. Linear IgA bullous dermatosis. e. Bullous contact dermatitis.
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
1
© 2014 The Society for Investigative Dermatology
www.jidonline.org
1
JID VisualDx Quiz
2. Increased IL-17 in blister fluid in bullous pemphigoid is most likely derived from what? a. T helper type 17 (Th17) cells. b. Neutrophils. c. Th2 cells. d. Langerhans cells. e. All of the above. 3. IL-17 leads to an increase in which of the following, which may maintain lesion development in bullous pemphigoid? a. Neutrophil elastase. b. Matrix metalloprotease-9. c. ADAM 12. d. Both a and b. e. All of the above.
TOPIC ARTICLE Questions 2 and 3 refer to the following article: Le Jan S, Plée J, Vallerand D et al. (2014) Innate immune cell–produced IL-17 sustains inflammation in bullous pemphigoid. J Invest Dermatol 134:2908–2917
Answers are available as supplementary material at http://dx.doi.org/10.1038/jid.2014.435.
2
Journal of Investigative Dermatology (2014), Volume 134
Copyright of Journal of Investigative Dermatology is the property of Nature Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
JID VisualDx Quiz: December 2014 Arsalan Shabbir1 and Robert S. Kirsner1 Journal of Investigative Dermatology (2014) 134, e23. doi:10.1038/jid.2014.435
JID and Logical Images, Inc., have cooperated to offer the JID VisualDx Quiz, incorporating diagnostic images from VisualDx’s vast database. Questions relate to the image as well as to selected articles in JID, which are listed after the questions. Answers will be posted as supplementary material. We hope you enjoy this challenge.
Image appears with permission from VisualDx. © Logical Images, Inc.
QUESTIONS 1. What is your diagnosis? a. Bullous pemphigoid. b. Epidermolysis bullosa acquista. c. Bullous drug reaction. d. Linear IgA bullous dermatosis. e. Bullous contact dermatitis.
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
1
© 2014 The Society for Investigative Dermatology
www.jidonline.org
1
JID VisualDx Quiz
2. Increased IL-17 in blister fluid in bullous pemphigoid is most likely derived from what? a. T helper type 17 (Th17) cells. b. Neutrophils. c. Th2 cells. d. Langerhans cells. e. All of the above. 3. IL-17 leads to an increase in which of the following, which may maintain lesion development in bullous pemphigoid? a. Neutrophil elastase. b. Matrix metalloprotease-9. c. ADAM 12. d. Both a and b. e. All of the above.
TOPIC ARTICLE Questions 2 and 3 refer to the following article: Le Jan S, Plée J, Vallerand D et al. (2014) Innate immune cell–produced IL-17 sustains inflammation in bullous pemphigoid. J Invest Dermatol 134:2908–2917
Answers are available as supplementary material at http://dx.doi.org/10.1038/jid.2014.435.
2
Journal of Investigative Dermatology (2014), Volume 134
Copyright of Journal of Investigative Dermatology is the property of Nature Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
